Chlamydial Heat Shock Protein 60 Activates Macrophages and Endothelial Cells Through Toll-Like Receptor 4 and MD2 in a MyD88-Dependent Pathway
Top Cited Papers
- 1 February 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 168 (3) , 1435-1440
- https://doi.org/10.4049/jimmunol.168.3.1435
Abstract
Active inflammation and NF-κB activation contribute fundamentally to atherogenesis and plaque disruption. Accumulating evidence has implicated specific infectious agents including Chlamydia pneumoniae in the progression of atherogenesis. Chlamydial heat shock protein 60 (cHSP60) has been implicated in the induction of deleterious immune responses in human chlamydial infections and has been found to colocalize with infiltrating macrophages in atheroma lesions. cHSP60 might stimulate, enhance, and maintain innate immune and inflammatory responses and contribute to atherogenesis. In this study, we investigated the signaling mechanism of cHSP60. Recombinant cHSP60 rapidly activated NF-κB in human microvascular endothelial cells (EC) and in mouse macrophages, and induced human IL-8 promoter activity in EC. The inflammatory effect of cHSP60 was heat labile, thus excluding a role of contaminating LPS, and was blocked by specific anti-chlamydial HSP60 mAb. In human vascular EC which express Toll-like receptor 4 (TLR4) mRNA and protein, nonsignaling TLR4 constructs that act as dominant negative blocked cHSP60-mediated NF-κB activation. Furthermore, an anti-TLR4 Ab abolished cHSP60-induced cellular activation, whereas a control Ab had no effect. In 293 cells, cHSP60-mediated NF-κB activation required both TLR4 and MD2. A dominant-negative MyD88 construct also inhibited cHSP60-induced NF-κB activation. Collectively, our results indicate that cHSP60 is a potent inducer of vascular EC and macrophage inflammatory responses, which are very relevant to atherogenesis. The inflammatory effects are mediated through the innate immune receptor complex TLR4-MD2 and proceeds via the MyD88-dependent signaling pathway. These findings may help elucidate the mechanisms by which chronic asymptomatic chlamydial infection contribute to atherogenesis.Keywords
This publication has 55 references indexed in Scilit:
- Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor ComplexJournal of Biological Chemistry, 2001
- Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial CellsJournal of Biological Chemistry, 2000
- Chlamydia pneumoniaeInfection Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient MiceThe Journal of Infectious Diseases, 1999
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear PhagocytesJournal of Biological Chemistry, 1999
- Health needs of imprisoned Ethiopian doctorThe Lancet, 1998
- ChronicChlamydia pneumoniaeInfection Is Associated With a Serum Lipid Profile Known to Be a Risk Factor for AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Detection of Chlamydia pneumoniae TWAR in Human Coronary Atherectomy TissuesThe Journal of Infectious Diseases, 1995
- Heat shock proteins and the immune responseImmunology Today, 1990
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988